FILE - In this June 6, 2011 file picture, the logo of Swiss drugmaker Roche is photographed in Rotkreuz, Switzerland. Roche Holding AG . Swiss pharmaceutical company Roche says it will buy InterMune, Inc., a California-based developer of treatments for lung diseases, in a deal worth US $8.3 billion. Roche said SundayAug. 24, 2014 the companies have reached an agreement under which Roche will acquire InterMune in an all-cash transaction, with Roche paying US$ 74.00 per InterMune share. That’s a
Zdroj:
Urs Flueeler
